Mikko Muona

Mikko Muona

Auto-generated profile, based on publicly available information

Mikko Muona

Research Program in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ICInternational Headache Genetics Consortium
International Headache Genetics Consortium
PGPadhraig Gormley
Padhraig Gormley
VAVerneri Anttila
Verneri Anttila
BWBendik S Winsvold
Bendik S Winsvold
PPPriit Palta
Priit Palta
APAarno Palotie
Aarno Palotie

17 November 2014 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MMMikko Muona
Mikko Muona
Sam BerkovicSam Berkovic
Sam Berkovic
LDLeanne M Dibbens
Leanne M Dibbens
KOKaren L Oliver
Karen L Oliver
SMSnezana Maljevic
Snezana Maljevic
ALAnna-Elina Lehesjoki
Anna-Elina Lehesjoki

4 March 2010 in Nature Protocols
Verified
Journal Article
Closed access
MMMikko Muona
Mikko Muona
AAA Sesilja Aranko
A Sesilja Aranko
VRVytas Raulinaitis
Vytas Raulinaitis
HIHideo Iwaï
Hideo Iwaï

28 June 2013 in Epilepsia
Verified
Journal Article
Open access
PDF file
EGEija Gaily
Eija Gaily
AAAnna‐Kaisa Anttonen
Anna‐Kaisa Anttonen
LVLeena Valanne
Leena Valanne
ELElina Liukkonen
Elina Liukkonen
ATAnn‐Liz Träskelin
Ann‐Liz Träskelin
ALAnna‐Elina Lehesjoki
Anna‐Elina Lehesjoki
Summary: Purpose: Dravet syndrome is an autosomal dominant epileptic encephalopathy of childhood, which is caused mainly by SCN1A and PCHD19 mutations. Although Dravet syndrome is well recognized, the causes of acute encephalopathy are still elusive, and reported data on ictal electroencephalography (EEG) and structural brain abnormalities are scarce.Methods: We studied 30 children who fulfilled the clinical criteria for Dravet syndrome. All patients were screened for SCN1A mutations and 25 for POLG mutations with bidirectional sequencing. Clinical data, including etiologic studies done as part of the clinical workup, were collected from hospital charts. Ictal video‐EEG recordings and magnetic resonance (MR) images were reanalyzed by the authors.Key Findings: SCN1A mutations were found in 25 patients (83%). Two SCN1A mutation–negative patients had chromosomal translocations involving chromosomes 9 and X, and one had a mutation in PCDH19. Prolonged seizures were associated with acute encephalopathy in three SCN1A mutation–positive patients. One showed evidence of a significant hypoxic–ischemic event during status epilepticus. The other two demonstrated new persistent neurologic deficits postictally; they both carried heterozygous POLG variants (p.Trp748Ser or p.Gly517Val). Hippocampal sclerosis or loss of gray–white matter definition in the temporal lobe was observed in 7 of 18 patients who had MRI after age 3 years (39%). Motor seizures were recorded on video‐EEG for 15 patients, of whom 12 were younger than 6 years at recording; 11 patients (73%) showed posterior onsets.Significance: Our data imply that a heterozygous X;9 translocation and rare POLG variants may modify the clinical features of Dravet syndrome. The latter may increase susceptibility for acute encephalopathy. Temporal lobe abnormalities are common in patients imaged after 3 years of age. Focal seizures seem to localize predominantly in the posterior regions in young children with Dravet syndrome.

7 May 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JDJohn A. Damiano
John A. Damiano
ZAZaid Afawi
Zaid Afawi
MBMelanie Bahlo
Melanie Bahlo
MMMonika Mauermann
Monika Mauermann
AMAdel Misk
Adel Misk
MHMichael S. Hildebrand
Michael S. Hildebrand
We studied a consanguineous Palestinian Arab family segregating an autosomal recessive progressive myoclonus epilepsy (PME) with early ataxia. PME is a rare, often fatal syndrome, initially responsive to antiepileptic drugs which over time becomes refractory and can be associated with cognitive decline. Linkage analysis was performed and the disease locus narrowed to chromosome 19p13.3. Fourteen candidate genes were screened by conventional Sanger sequencing and in one, LMNB2, a novel homozygous missense mutation was identified that segregated with the PME in the family. Whole exome sequencing excluded other likely pathogenic coding variants in the linked interval. The p.His157Tyr mutation is located in an evolutionarily highly conserved region of the alpha-helical rod of the lamin B2 protein. In vitro assembly analysis of mutant lamin B2 protein revealed a distinct defect in the assembly of the highly ordered fibrous arrays typically formed by wild-type lamin B2. Our data suggests that disruption of the organisation of the nuclear lamina in neurons, perhaps through abnormal neuronal migration, causes the epilepsy and early ataxia syndrome and extends the aetiology of PMEs to include dysfunction in nuclear lamin proteins.

9 December 2008 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
MMMikko Muona
Mikko Muona
AAA. Sesilja Aranko
A. Sesilja Aranko
HIHideo Iwaï
Hideo Iwaï